NO20053575L - Metallprotease proteiner - Google Patents

Metallprotease proteiner

Info

Publication number
NO20053575L
NO20053575L NO20053575A NO20053575A NO20053575L NO 20053575 L NO20053575 L NO 20053575L NO 20053575 A NO20053575 A NO 20053575A NO 20053575 A NO20053575 A NO 20053575A NO 20053575 L NO20053575 L NO 20053575L
Authority
NO
Norway
Prior art keywords
proteins
protease proteins
metal protease
insp005b
insp005a
Prior art date
Application number
NO20053575A
Other languages
English (en)
Other versions
NO20053575D0 (no
Inventor
Ursula Boschert
Yolande Chvatchko
Christine Power
Richard Joseph Fagan
Christopher Benjamin Phelps
Richard James Mitter
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20053575D0 publication Critical patent/NO20053575D0/no
Publication of NO20053575L publication Critical patent/NO20053575L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)

Abstract

Foreliggende oppfinnelse gjelder nye proteiner, betegnet INSP005a og INSP005b, heri vist å være utskilte proteiner, nærmere bestemt medlem av metalloproteasefamilien, samt anvendelse av disse proteinene og nukleinsyresekvenser fra de kodende genene for diagnose, forebyggelse og behandling av sykdom.
NO20053575A 2002-12-23 2005-07-21 Metallprotease proteiner NO20053575L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0230006.9A GB0230006D0 (en) 2002-12-23 2002-12-23 Proteins
PCT/GB2003/005664 WO2004056983A2 (en) 2002-12-23 2003-12-23 Metalloprotease proteins

Publications (2)

Publication Number Publication Date
NO20053575D0 NO20053575D0 (no) 2005-07-21
NO20053575L true NO20053575L (no) 2005-09-23

Family

ID=9950313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053575A NO20053575L (no) 2002-12-23 2005-07-21 Metallprotease proteiner

Country Status (11)

Country Link
US (1) US7557079B2 (no)
EP (1) EP1583825B1 (no)
JP (1) JP5053516B2 (no)
AT (1) ATE526400T1 (no)
AU (1) AU2003290342B2 (no)
CA (1) CA2510066A1 (no)
ES (1) ES2374392T3 (no)
GB (1) GB0230006D0 (no)
IL (1) IL169256A (no)
NO (1) NO20053575L (no)
WO (1) WO2004056983A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100183617A1 (en) * 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
GB0921001D0 (en) * 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
CN109957557B (zh) * 2017-12-26 2023-01-06 广州市锐博生物科技有限公司 Dna聚合酶及其制备方法
CN114032252B (zh) * 2021-11-01 2022-04-22 武汉爱博泰克生物科技有限公司 一种重组状态人源mmp-7蛋白的表达方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311692A2 (en) 2000-08-23 2003-05-21 Applera Corporation Robert A. Millman Assistant Secretary Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
CA2473197A1 (en) * 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same
US20050107293A1 (en) 2001-09-14 2005-05-19 Sprague William W. Protein modification and maintenance molecules

Also Published As

Publication number Publication date
IL169256A0 (en) 2007-07-04
EP1583825B1 (en) 2011-09-28
US7557079B2 (en) 2009-07-07
ATE526400T1 (de) 2011-10-15
AU2003290342B2 (en) 2009-09-24
ES2374392T3 (es) 2012-02-16
CA2510066A1 (en) 2004-07-08
US20060252117A1 (en) 2006-11-09
IL169256A (en) 2010-11-30
EP1583825A2 (en) 2005-10-12
AU2003290342A1 (en) 2004-07-14
NO20053575D0 (no) 2005-07-21
WO2004056983A3 (en) 2006-02-09
WO2004056983A2 (en) 2004-07-08
JP5053516B2 (ja) 2012-10-17
GB0230006D0 (en) 2003-01-29
JP2006516888A (ja) 2006-07-13

Similar Documents

Publication Publication Date Title
NO20052956L (no) Defensinprotiner
WO2003055912A3 (en) Secreted proteins
NO20053575D0 (no) Metallprotease proteiner
WO2006046073A3 (en) C1q related protein
WO2004096856A3 (en) Secreted protein family
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
UA93658C2 (en) Cell surface glycoprotein
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
WO2004053117A3 (en) Serine protease
WO2003054178A3 (en) Metalloprotease proteins
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
EA200501843A1 (ru) Tnf-подобный секретируемый белок
WO2004035626A8 (en) Alpha macroglobulin protein family members
WO2007049062A3 (en) Vwfa-domain containing proteins
WO2002062976A3 (en) Serine proteases
WO2004101618A3 (en) Progestin-yol002c-cgi-45 receptor-related proteins
WO2004041861A3 (en) Alpha macroglobulin family member
WO2004026905A3 (en) Transporter/channel proteins
WO2002062845A3 (en) Adhesion molecules
WO2004000882A3 (en) Proteins
WO2002044382A8 (en) Cytokine-like proteins
WO2004011648A3 (en) CYTOCHROME P450s
WO2002088341A3 (en) P450 proteins
WO2003089469A3 (en) Cation channel proteins
WO2004024762A3 (en) Il-8 like protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application